HCAR3: an underexplored metabolite sensor.
作者信息
Kapolka Nicholas J, Isom Daniel G
出版信息
Nat Rev Drug Discov. 2020 Nov;19(11):745. doi: 10.1038/d41573-020-00173-2.
Abstract
摘要
相似文献
1
HCAR3: an underexplored metabolite sensor.HCAR3：一种尚未充分研究的代谢物传感器。
Nat Rev Drug Discov. 2020 Nov;19(11):745. doi: 10.1038/d41573-020-00173-2.
2
Alterations in Kynurenine and NAD Salvage Pathways during the Successful Treatment of Inflammatory Bowel Disease Suggest HCAR3 and NNMT as Potential Drug Targets.在炎症性肠病的成功治疗过程中，犬尿氨酸和 NAD 补救途径的改变表明 HCAR3 和 NNMT 可能是潜在的药物靶点。
Int J Mol Sci. 2021 Dec 16;22(24):13497. doi: 10.3390/ijms222413497.
3
Nicotinic and opioid receptor interactions in nicotine addiction.尼古丁成瘾中烟碱型和阿片受体的相互作用。
Mol Interv. 2006 Dec;6(6):311-4. doi: 10.1124/mi.6.6.4.
4
It ain't over 'til the fat lady sings.不到最后关头，决不放弃。
Sci Transl Med. 2012 Aug 22;4(148):148fs30. doi: 10.1126/scitranslmed.3004445.
5
Stretching and setting boundaries.伸展并设定界限。
J Gen Physiol. 2012 Oct;140(4):341-2. doi: 10.1085/jgp.201210895.
6
GPR109a: the missing link between microbiome and good health?GPR109a：微生物组与健康之间缺失的一环？
Immunity. 2014 Jan 16;40(1):8-10. doi: 10.1016/j.immuni.2013.12.009.
7
Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug?一种烟酸受体的鉴定：这是最古老的降脂药物的分子靶点吗？
Curr Opin Investig Drugs. 2004 Mar;5(3):271-5.
8
Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.鉴定和验证 HCAR3 和 INSL5 为结直肠癌新的潜在治疗靶点。
World J Surg Oncol. 2021 Aug 21;19(1):248. doi: 10.1186/s12957-021-02335-x.
9
Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission.烟碱型和阿片型受体对纹状体多巴胺 D2 受体介导的传递的调节。
Sci Rep. 2016 Nov 25;6:37834. doi: 10.1038/srep37834.
10
GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors.GPR109A、GPR109B 和 GPR81，一个羟基羧酸受体家族。
Trends Pharmacol Sci. 2009 Nov;30(11):557-62. doi: 10.1016/j.tips.2009.09.001.
引用本文的文献
1
HCAR3 and Kynurenic Acid in Cancer: A Promising Axis of Immunometabolic Regulation or a Scientific Mirage?癌症中的HCAR3与犬尿氨酸：一条有前景的免疫代谢调控轴还是科学幻想？
Int J Mol Sci. 2025 Jun 28;26(13):6269. doi: 10.3390/ijms26136269.
2
Drug Repurposing to Inhibit Oncostatin M in Crohn's Disease.药物再利用以抑制克罗恩病中的制瘤素M
Molecules. 2025 Apr 24;30(9):1897. doi: 10.3390/molecules30091897.
3
Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis.探索炎症性肠病中的微生物代谢物受体：对其在炎症和纤维化中潜在作用的计算机模拟分析
Pharmaceuticals (Basel). 2024 Apr 12;17(4):492. doi: 10.3390/ph17040492.
4
Our extended microbiome: The human-relevant metabolites and biology of fermented foods.我们扩展的微生物组：发酵食品的人类相关代谢物和生物学。
Cell Metab. 2024 Apr 2;36(4):684-701. doi: 10.1016/j.cmet.2024.03.007.
5
A Review on the Role and Function of Cinnabarinic Acid, a "Forgotten" Metabolite of the Kynurenine Pathway.对犬尿氨酸途径中一种“被遗忘”的代谢产物——朱红酸的作用和功能的综述
Cells. 2024 Mar 5;13(5):453. doi: 10.3390/cells13050453.
6
Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia.精神分裂症患者背外侧前额叶皮质灰质和白质中犬尿氨酸代谢物的变化。
Schizophrenia (Heidelb). 2024 Feb 27;10(1):27. doi: 10.1038/s41537-024-00447-3.
7
The Neurochemistry of Depression: The Good, The Bad and The Ugly.抑郁症的神经化学：好的、坏的和丑的。
Mo Med. 2024 Jan-Feb;121(1):68-75.
8
GPCR Screening Reveals that the Metabolite Receptor HCAR3 Regulates Epithelial Proliferation, Migration, and Cellular Respiration.GPCR 筛选揭示代谢物受体 HCAR3 调节上皮细胞增殖、迁移和细胞呼吸。
J Invest Dermatol. 2024 Jun;144(6):1311-1321.e7. doi: 10.1016/j.jid.2023.12.002. Epub 2023 Dec 14.
9
Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2.关于人类羟基羧酸受体HCAR2的配体识别和选择性的结构见解。
Cell Discov. 2023 Nov 28;9(1):118. doi: 10.1038/s41421-023-00610-7.
10
The Promise of Niacin in Neurology.烟酸在神经病学中的应用前景。
Neurotherapeutics. 2023 Jul;20(4):1037-1054. doi: 10.1007/s13311-023-01376-2. Epub 2023 Apr 21.
Zotero 插件